Rivaroxaban Market Growth Supported by Expanding Healthcare Access
Market experts are observing transformative trends in the Rivaroxaban landscape, indicating a shift in the market dynamics that could redefine its future. By 2035, the Rivaroxaban market is anticipated to grow from USD 8.16 billion in 2024 to an impressive USD 16.01 billion, reflecting a healthy compound annual growth rate (CAGR) of 6.32%. This growth is primarily driven by the escalating...
0 Commentaires 0 Parts 97 Vue 0 Aperçu